|
注册号: Registration number: |
ChiCTR-ONRC-12002018 |
|
最近更新日期: Date of Last Refreshed on: |
2015-08-04 19:12:33 |
|
注册时间: Date of Registration: |
2012-02-20 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
恶性肿瘤患者心理测评分析及其相关临床研究 |
|
Public title: |
An analysis about psychological evaluation of patients sufferring from malignant tumor and relevant clinical research |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
恶性肿瘤患者心理测评分析及其相关临床研究 |
|
Scientific title: |
An analysis about psychological evaluation of patients sufferring from malignant tumor and relevant clinical research |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
郭俊召 |
研究负责人: |
刘文超 |
|
Applicant: |
Junzhao Guo |
Study leader: |
Wenchao Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 029 84775412 |
研究负责人电话:
Study leader's |
+86 029 84775407 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
adermenguo@126.com |
研究负责人电子邮件: Study leader's E-mail: |
liuch@fmmu.edu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
西安市长乐西路32号 |
研究负责人通讯地址: |
西安市长乐西路32号 |
|
Applicant address: |
32 West Changle Road, Xi'an, Shaanxi |
Study leader's address: |
32 West Changle Road, Xi'an, Shaanxi |
|
申请注册联系人邮政编码: Applicant postcode: |
710032 |
研究负责人邮政编码: Study leader's postcode: |
710032 |
|
申请人所在单位: |
第四军医大学西京医院肿瘤科 |
||
|
Applicant's institution: |
Oncology Center, Xijing Hosipital, the Fourth Military Medical University |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
xjs_zlk_20120217 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
第四军医大学西京医院人体器官移植技术临床应用与伦理委员会 |
||
|
Name of the ethic committee: |
Clinical application and ethics committee of human organ transplantation technology,XiJing hospital , The fourth military medical university |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2012-02-17 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
第四军医大学西京医院肿瘤科 |
||||||||||||||||||||||
|
Primary sponsor: |
Oncology Center, Xijing Hosipital, the Fourth Military Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
西安市长乐西路32号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
32 West Changle Road, Xi'an, Shaanxi |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
funded by ourselves |
||||||||||||||||||||||
|
研究疾病: |
恶性肿瘤 |
||||||||||||||||||||||
|
Target disease: |
malignant tumor |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
肿瘤患者在接受放、化疗的同时,进行有效的心理干预,消除患者焦虑、恐惧、紧张等心理障碍,使其及时调整心态积极配合治疗,以期达到增进治疗效果、提高依从性、促进患者全面康复。 |
||||||||||||||||||||||
|
Objectives of Study: |
To eliminate patient's psychological barrieries such as anxiety, fear, stress and so on,we carry out effective psychological intervention on patients who suffer from maligant tumors together with chemotherapy or radiotherapy to make them adjust themselves timely and cooperate with treatment actively, in order to improve treatment effect, improve compliance, promote comprehensive recovery of patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.患自身免疫性疾病; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. With autoimmune diseases; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2012-01-01 00:00:00至 To 2014-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2012-01-01 00:00:00 至 To 2014-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
non randomised |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
|
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
|
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
|
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
|
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
|
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |